User profiles for "author:C Aguado"

Carmen Aguado

- Verified email at ciberer.es - Cited by 2154

Cristina Aguado

- Verified email at panoncology.com - Cited by 1365

CAROLINA AGUADO

- Verified email at uclm.es - Cited by 1271

New insights into the therapeutic potential of Girk channels

R Luján, EMF de Velasco, C Aguado… - Trends in neurosciences, 2014 - cell.com
G protein-dependent signaling pathways control the activity of excitable cells of the nervous
system and heart, and are the targets of neurotransmitters, clinically relevant drugs, and …

[HTML][HTML] Liquid biopsy in non-small cell lung cancer

…, C Teixido, B Garcia-Pelaez, C Aguado… - Frontiers in …, 2016 - frontiersin.org
Liquid biopsy analyses are already incorporated in the routine clinical practice in many
hospitals and oncology departments worldwide, improving the selection of treatments and …

Intracellular protein degradation in mammalian cells: recent developments

E Knecht, C Aguado, J Cárcel, I Esteban… - Cellular and Molecular …, 2009 - Springer
In higher organisms, dietary proteins are broken down into amino acids within the digestive
tract but outside the cells, which incorporate the resulting amino acids into their metabolism …

[HTML][HTML] Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state

N Salvador, C Aguado, M Horst, E Knecht - Journal of Biological Chemistry, 2000 - ASBMB
We have analyzed the folding state of cytosolic proteins imported in vitro into lysosomes,
using an approach originally developed by Eilers and Schatz,(Eilers, M., and Schatz …

Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations

…, B Pérez, LR Desviat, C Aguado… - Proceedings of the …, 2004 - National Acad Sciences
Phenylketonuria patients harboring a subset of phenylalanine hydroxylase (PAH) mutations
have recently shown normalization of blood phenylalanine levels upon oral administration of …

Laforin, the most common protein mutated in Lafora disease, regulates autophagy

C Aguado, S Sarkar, VI Korolchuk… - Human molecular …, 2010 - academic.oup.com
Lafora disease (LD) is an autosomal recessive, progressive myoclonus epilepsy, which is
characterized by the accumulation of polyglucosan inclusion bodies, called Lafora bodies, in …

Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy

O Criado, C Aguado, J Gayarre… - Human molecular …, 2012 - academic.oup.com
Lafora disease (LD), a fatal neurodegenerative disorder characterized by the presence of
intracellular inclusions called Lafora bodies (LBs), is caused by loss-of-function mutations in …

Regulation of glycogen synthesis by the laforin–malin complex is modulated by the AMP-activated protein kinase pathway

…, M Sanchez-Piris, C Aguado… - Human molecular …, 2008 - academic.oup.com
Lafora progressive myoclonus epilepsy (LD) is a fatal autosomal recessive
neurodegenerative disorder characterized by the presence of glycogen-like intracellular …

Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations

…, B Pérez, LR Desviat, MA Martínez, C Aguado… - Human …, 2004 - Wiley Online Library
A subtype of phenylalanine hydroxylase (PAH) deficiency that responds to cofactor
(tetrahydrobiopterin, BH4) supplementation has been associated with phenylketonuria …

L-DOPA oppositely regulates synaptic strength and spine morphology in D1 and D2 striatal projection neurons in dyskinesia

LM Suarez, O Solis, C Aguado, R Lujan… - Cerebral …, 2016 - academic.oup.com
Dopamine depletion in Parkinson's disease (PD) produces dendritic spine loss in striatal
medium spiny neurons (MSNs) and increases their excitability. However, the synaptic …